Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Price Performance

Shares of NASDAQ:AEMD opened at $0.67 on Friday. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.10. The company’s 50 day simple moving average is $0.50 and its 200 day simple moving average is $0.44. The stock has a market capitalization of $9.31 million, a price-to-earnings ratio of -0.24 and a beta of 1.61.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.